Media Zoom
S.Korea approves first domestically developed COVID vaccine
2022.06.29
SEOUL, June 29 (Reuters) - South Korea approved its first domestically developed COVID-19 vaccine, manufactured by SK bioscience Co Ltd (302440.KS), for general public use following positive clinical data, authorities said on Wednesday.
The SKYCovione vaccine was authorised for a two-dose regimen on people aged 18 or older, with shots given four weeks apart, according to the Ministry of Food and Drug Safety.